BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2721560)

  • 1. Antagonism by tubocurarine and verapamil of the regenerative acetylcholine release from mouse motor nerve.
    Hong SJ; Chang CC
    Eur J Pharmacol; 1989 Mar; 162(1):11-7. PubMed ID: 2721560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation by 3,4-diaminopyridine of regenerative acetylcholine release from mouse motor nerve.
    Hong SJ; Chang CC
    Br J Pharmacol; 1990 Dec; 101(4):793-8. PubMed ID: 1964819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological and regenerative acetylcholine release from motor nerve: differential inhibitions by vesamicol and omega-agatoxin IVA.
    Hong SJ; Lee SH; Chang CC
    Neuroscience; 1995 Jul; 67(1):169-75. PubMed ID: 7477897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular block by verapamil and diltiazem and inhibition of acetylcholine release.
    Chang CC; Lin SO; Hong SJ; Chiou LC
    Brain Res; 1988 Jun; 454(1-2):332-9. PubMed ID: 3409016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regenerating release of acetylcholine from mouse motor nerve terminals treated with anticholinesterase agents.
    Chang CC; Hong SJ
    Neurosci Lett; 1986 Aug; 69(2):203-7. PubMed ID: 3763048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.
    Tian L; Prior C; Dempster J; Marshall IG
    J Physiol; 1994 May; 476(3):517-29. PubMed ID: 7914535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by neosurugatoxin and omega-conotoxin of acetylcholine release and muscle and neuronal nicotinic receptors in mouse neuromuscular junction.
    Hong SJ; Tsuji K; Chang CC
    Neuroscience; 1992; 48(3):727-35. PubMed ID: 1318519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicardipine inhibits axon conduction but causes dual changes of acetylcholine release in the mouse motor nerve.
    Chang CC; Chiou LC; Hwang LL; Hong SJ; Huang CY
    Can J Physiol Pharmacol; 1989 Dec; 67(12):1493-8. PubMed ID: 2483357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic calcium channel antagonists provoke acetylcholine receptor autodesensitization on train stimulation of motor nerve.
    Chang CC; Huang CY; Hong SJ
    Neuroscience; 1990; 38(3):731-42. PubMed ID: 2125333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitter-mediated local contracture of the endplate region of the focally innervated mouse diaphragm treated with anticholinesterase.
    Hong SJ; Chang CC
    Br J Pharmacol; 1993 Aug; 109(4):1178-85. PubMed ID: 8104646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinic actions of oxotremorine on murine skeletal muscle. Evidence against muscarinic modulation of acetylcholine release.
    Hong SJ; Chang CC
    Brain Res; 1990 Nov; 534(1-2):142-8. PubMed ID: 2073579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.
    Fann ML; Souccar C; Lapa AJ
    Br J Pharmacol; 1990 Jul; 100(3):441-6. PubMed ID: 2390670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (+)-tubocurarine on [3H]acetylcholine release from the rat phrenic nerve at different stimulation frequencies and train lengths.
    Wessler I; Rasbach J; Scheuer B; Hillen U; Kilbinger H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):496-501. PubMed ID: 3614386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA.
    Hong SJ; Chang CC
    J Physiol; 1995 Jan; 482 ( Pt 2)(Pt 2):283-90. PubMed ID: 7714822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the synergistic interactions between organic calcium channel antagonists and various neuromuscular blocking agents.
    Chang CC; Chiou LC; Hwang LL; Huang CY
    Jpn J Pharmacol; 1990 Jul; 53(3):285-92. PubMed ID: 2167989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the low-frequency associated nicotinic ACh autoreceptor-mediated depression of ACh release from rat motor nerve terminals.
    Prior C; Singh S
    Br J Pharmacol; 2000 Mar; 129(6):1067-74. PubMed ID: 10725254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succinylcholine-induced acceleration and suppression of electrically evoked acetylcholine release from mouse phrenic nerve-hemidiaphragm muscle preparation.
    Kimura I; Okazaki M; Uwano T; Kobayashi S; Kimura M
    Jpn J Pharmacol; 1991 Nov; 57(3):397-403. PubMed ID: 1813665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of quantal release from motor nerve by wortmannin.
    Hong SJ; Chang CC
    Br J Pharmacol; 1999 Sep; 128(1):142-8. PubMed ID: 10498845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.